Everence Capital Management Inc. Buys Shares of 14,050 AdaptHealth Corp. (NASDAQ:AHCO)

Everence Capital Management Inc. bought a new stake in AdaptHealth Corp. (NASDAQ:AHCO) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 14,050 shares of the company’s stock, valued at approximately $102,000.

Other large investors have also recently bought and sold shares of the company. Quarry LP bought a new position in AdaptHealth in the second quarter valued at about $33,000. PNC Financial Services Group Inc. raised its position in AdaptHealth by 653.7% in the second quarter. PNC Financial Services Group Inc. now owns 2,962 shares of the company’s stock valued at $36,000 after purchasing an additional 2,569 shares during the last quarter. Tower Research Capital LLC TRC raised its position in shares of AdaptHealth by 610.0% during the first quarter. Tower Research Capital LLC TRC now owns 3,394 shares of the company’s stock worth $42,000 after acquiring an additional 2,916 shares during the last quarter. Dark Forest Capital Management LP raised its position in shares of AdaptHealth by 31,871.4% during the first quarter. Dark Forest Capital Management LP now owns 4,476 shares of the company’s stock worth $56,000 after acquiring an additional 4,462 shares during the last quarter. Finally, Group One Trading L.P. raised its position in shares of AdaptHealth by 134.3% during the first quarter. Group One Trading L.P. now owns 3,720 shares of the company’s stock worth $60,000 after acquiring an additional 2,132 shares during the last quarter. 82.67% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Royal Bank of Canada restated an “outperform” rating and set a $13.00 price objective on shares of AdaptHealth in a research report on Monday, March 4th. UBS Group raised their price objective on AdaptHealth from $9.00 to $13.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Truist Financial raised their price objective on AdaptHealth from $11.00 to $13.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Finally, Jefferies Financial Group downgraded AdaptHealth from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $14.50 to $8.00 in a research report on Monday, January 8th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $12.10.

Insider Activity at AdaptHealth

In related news, major shareholder James E. Flynn sold 52,487 shares of AdaptHealth stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $10.93, for a total transaction of $573,682.91. Following the transaction, the insider now owns 11,826,376 shares of the company’s stock, valued at $129,262,289.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, major shareholder James E. Flynn sold 182,607 shares of AdaptHealth stock in a transaction on Monday, March 11th. The stock was sold at an average price of $11.02, for a total transaction of $2,012,329.14. Following the sale, the insider now directly owns 11,643,769 shares in the company, valued at $128,314,334.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder James E. Flynn sold 52,487 shares of AdaptHealth stock in a transaction on Friday, March 8th. The stock was sold at an average price of $10.93, for a total value of $573,682.91. Following the sale, the insider now owns 11,826,376 shares in the company, valued at $129,262,289.68. The disclosure for this sale can be found here. 13.60% of the stock is owned by insiders.

AdaptHealth Stock Down 0.2 %

Shares of NASDAQ:AHCO opened at $9.34 on Friday. The stock has a market cap of $1.24 billion, a price-to-earnings ratio of -1.76, a PEG ratio of 0.62 and a beta of 1.02. The company has a quick ratio of 1.00, a current ratio of 1.21 and a debt-to-equity ratio of 1.44. AdaptHealth Corp. has a 12-month low of $6.37 and a 12-month high of $15.37. The business’s 50 day moving average is $9.82 and its 200 day moving average is $8.38.

AdaptHealth (NASDAQ:AHCO) last announced its earnings results on Tuesday, February 27th. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.44. The company had revenue of $858.23 million for the quarter, compared to analysts’ expectations of $825.94 million. AdaptHealth had a positive return on equity of 8.84% and a negative net margin of 21.21%. On average, sell-side analysts forecast that AdaptHealth Corp. will post 0.88 earnings per share for the current fiscal year.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.